Ind-Swift Ltd
INDSWFTLTD
Company Profile
Business description
Ind-Swift Ltd is an India-based pharmaceutical company. It engages in the manufacturing and marketing of pharmaceutical products. The company's products are classified into divisions namely, Generic Division, NOVA Division, Ethical Division, Nobel Division, Herba Plus Division, Institution Division, and Proposed Division. The manufacturing facilities of the firm are situated in (Derabassi)Punjab, India. Substantial revenue accrues from export sales of products.
Contact
781, Industrial Area
Phase II
Chandigarh160002
INDT: +91 1722638781
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,054
Stocks News & Analysis
video
What does the RBA rate cut mean for investors?
Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.
stocks
Insights from reporting season: So far, so good
We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.
stocks
3 cheap ASX stocks owned by top rated funds
Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,570.90 | 30.80 | -0.36% |
| CAC 40 | 8,154.51 | 31.93 | 0.39% |
| DAX 40 | 22,287.56 | 27.09 | -0.12% |
| Dow JONES (US) | 43,725.89 | 450.76 | -1.02% |
| FTSE 100 | 8,659.37 | 3.60 | -0.04% |
| HKSE | 23,477.92 | 900.94 | 3.99% |
| NASDAQ | 19,764.02 | 198.34 | -0.99% |
| Nikkei 225 | 38,776.94 | 98.90 | 0.26% |
| NZX 50 Index | 12,752.58 | 127.78 | -0.99% |
| S&P 500 | 6,071.32 | 46.20 | -0.76% |
| S&P/ASX 200 | 8,296.20 | 26.60 | -0.32% |
| SSE Composite Index | 3,379.11 | 28.33 | 0.85% |